BCL2 and cancer: A hallmark of cancer cells is their ability to suppress pro-apoptotic pathways and/or to activate anti-apoptotic mechanisms 78, 250 associated with drug resistance 304, such as the Bcl-2 family of proteins and HK, preventing the release of Cyto c from mitochondria.